Preview

Systemic Hypertension

Advanced search

Фиксированные комбинации - оптимальная стратегия лечения пациентов с артериальной гипертензией. Новая комбинация b-блокатора и диуретика - Лодоз

About the Authors

О. Остроумова
ГОУ ВПО МГМСУ Росздрава, Москва
Russian Federation


А. Средняков
ГОУ ВПО МГМСУ Росздрава, Москва
Russian Federation


Т. Гусева
ГОУ ВПО МГМСУ Росздрава, Москва
Russian Federation


References

1. И.Е.Чазова, Л.Г.Ратова. Комбинированная терапия артериальной гипертонии. М.: Медиа Медика, 2007.

2. BENETOS A, COSOLI S, SAFAVIAN A, et al.: Efficacy, safety and effects on quality of life of Bisoprolol/Hydrochlorothiazide versus Amlodipine in elderly patients with systolic hypertension. Am Heart J 2000; 140: e14.

3. DeQUATTRO V, WEIR M. Bisoprolol fumarate/Hydrochlorothiazide 6.25 mg: A new low-dose option for first-line antihypertensive therapy. Advances in therapy 1993; 10 (5): 197-206.

4. FRISHMAN WH, BRYZINSKI BS, COULSON LR, et al. A multifactorial trial design to assess combination therapy in hypertension: Treatment with Bisoprolol and Hydrochlorothiazide. Arch Intern Med. 1994; 154: 1461-1468.

5. FRISHMAN WH, BURRIS JF, MROCZEK WJ, et al. First-line therapy option with low-dose Bisoprolol fumarate and low-dose Hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol. 1995; 35: 182-188.

6. FRISHMAN WH. ZIAC National Hypertension Trial Report. March 1996.

7. HABIB GB . Reappraisal of heart rate as a risk factor in the general population. Eur Heart J 1999; 1 (Suppl H): H2-H10.

8. JNC VI/The Sixth Report of the Joint National Commitee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, NIH Publications 1997; No. 98-4080.

9. LEWIN AJ, LEUG MC, TARGUM S, et al. A clinical trial evaluating the 24-hour effects of Bisoprolol 5/Hydrochlorothiazide 6.25 combination in patients with mild-to-moderate hypertension. Clin Cardiol. 1993; 16: 732-736.

10. MOSER M, BLACK H. The role of combination therapy in the treatment of hypertension. Am J Hypertens 1998; 11: 73S-78S.

11. NEUTEL JM, ROLF CN, VALENTINE SN, et al. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: the efficacy and safety of Bisoprolol/6.25 HCTZ versus Amlodipine, Enalapril, and placebo. Cardiovasc Rev Rep. 1996; 17: 33-45.

12. PAPADEMETRIOU V, NEUTEL J, NARAVAN P, et al. Comparison of Bisoprolol and low dose Hydrochlorothiazide combination with Losartan, alone or in combination with Hydrochlorothiazide, in the treatment of hypertension: a double blind, randomized, placebo controlled trial. Cardiovasc Rev Rep.; December 1998.

13. PRISANT LM, WEIR MR, PAPADEMETRIOU V, et al. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. Am Heart J. 1995; 130: 359-366.

14. PRISANT LM, NEUTEL JM, PAPADEMETRIOU V, et al. Low-dose combination treatment for hypertension versus single-drug treatment - Bisoprolol/Hydrochlorothiazide versus Amlodipine, Enalapril, and placebo: Combined analysis of comparative studies. Am J Ther .1998; 5: 313-321.

15. PRISANT LM, WEIR MR, FRISHMANWH, et al.: Self reported Sexual Dysfunction in Men and Woman Treated With Bisoprolol, Hydrochlorothiazide, Enalapril, Placebo, or Bisoprolol/Hydrochlorothiazide. J Clin Hypertens. 1999; 1:22-26.

16. o PRISANT LM, MOSER M: Hypertension in the Elderly. Arch Intern Med. 2000; 160: 283-289.

17. WEIR MR, PRISANT LM, PAPADEMETRIOU V et al. Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events and prior antihypertensive therapy. Am J Hypertens. 1996; 9: 854-859.


Review

For citations:


 ,  ,   . Systemic Hypertension. 2008;(2):8-11.

Views: 81


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)